A non-hormonal radiofrequency treatment improved sexual function and vaginal health in postmenopausal women, according to results from a small randomised study. The study assessed nonablative capacitive-resistive...
Menopause hair loss trial data showed what the company called clinically meaningful regrowth from a scalp system in a phase II study of menopausal women. The...
Menopause is linked to grey matter shifts in brain regions for memory and emotion, with poorer sleep and higher anxiety or depression, a study suggests. The...
GenM is taking its menopause certification to Australia with TerryWhite Chemmart, Australia’s largest pharmacy network. The tie-up marks the first time GenM’s MTick menopause-friendly shopping symbol...
Digital diagnostics company Medichecks has acquired specialist menopause health platform and clinic My Menopause Centre. The deal is part of Medichecks’ move into clinical services and...
Menopause specialist Dr Mary Claire Haver has been appointed as the first chief agewell officer at virtual care clinic Midi Health. In the role, Dr Haver...
Mira has integrated with Oura, letting users see sleep, readiness and temperature trends alongside hormone readings in the Mira app. The integration lets Mira users view...
Women with ADHD are nearly twice as likely to experience perimenopause symptoms compared with women without ADHD, new research has revealed. The study reported 54 per...
Midi Health has closed a US$100m Series D, lifting the menopause care provider to a valuation above US$1bn and achieving unicorn status. The company, originally focused...
IBSA UK has introduced Hyaluxelle, a non-hormonal menopause treatment for vulvo-vaginal atrophy, easing vaginal dryness and pain during intercourse. Hyaluxelle is given as deep intradermal injections...
